• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Only low risk of HIV transmission among those well controlled on antiretroviral therapy

byMichael Milligan
July 13, 2016
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. This prospective study found no instances of HIV transmission among serodiscordant couples engaging in condomless sexual intercourse when the HIV-infected partner was taking antiretroviral therapy and maintaining a viral load below 200 copies/mL.

2. The calculated upper limit of HIV transmission risk in these couples is 0.3 per 100 couple-years overall, and 0.71 per 100 couple-years for anal intercourse.

Evidence Rating Level: 2 (Good)

Study Rundown: It has been long established that HIV-infection can be spread primarily by sexual contact, among other routes. Previous studies have shown that the use of antiretroviral therapy (ART) can reduce the rate of transmission by as much as 96%. Therefore, the World Health Organization has recommended the widespread use of ART in all HIV-infected patients, regardless of CD4 count, in an effort to stem the spread of disease. However, much of the data used to support this guideline have come from studies in which couples have reported diligent condom use. Thus, to determine the effectiveness of this recommendation in a broader population, the Partners of People on ART – A New Evaluation of the Risks (PARTNER) study sought to determine the rate of transmission in couples reporting condomless intercourse. This study followed a large number of serodiscordant couples that engaged in condomless sex in which the HIV-infected partner was taking ART and maintained a viral load below 200 copies/mL. It found a transmission rate of 0% for all forms of sex. The upper confidence limit of transmission was calculated to be 0.3/100 couple-years overall, and 0.71/100 couple-years for anal penetrative sex.

This study shows that the rate of HIV transmission is low among serodiscordant couples in which the HIV-infected partner is well controlled on ART. However, it was not designed to estimate the risk of transmission at different points of infection and was conducted with only a minimal duration of follow-up. Thus, longer-term studies are needed to provide more precise temporal estimates of risk.

Click to read the study in JAMA

RELATED REPORTS

Weekly islatravir plus lenacapavir maintains HIV virologic suppression

Ending Ryan White services may increase human immunodeficiency virus incidence

Relevant Reading: Viral load and heterosexual transmission of Human Immunodeficiency Virus type 1

FDA approvedFor HIV: Idvynso (doravirine and islatravir), Apr 20, 2026→

In-Depth [prospective cohort]: The PARTNER trial observed a total of 1166 HIV serodiscordant couples from 14 different countries who reported condomless sexual intercourse between September 2010 and May 2014. Couples were eligible for enrollment as long as the HIV-infected partner was taking suppressive ART and their HIV-1 RNA load remained less than 200 copies/mL. A total of 888 couples (548 heterosexual, 340 MSM) reported information over a mean follow-up of 1.3 years. Couples that contributed data tended to be older, engage in longer durations of condomless sex, and have higher CD4 counts on average. During follow-up couples engaged in condomless sex 37 times per year on average. By the end of the study period, 11 total HIV-negative partners became infected (10 MSM, 1 heterosexual, 8 reported condomless sex with partners outside of their studied relationship), however, no transmission of phylogenetically linked virus occurred. Thus, the overall rate of within-couple HIV transmission was reported as 0 (transmission rate 95% CI 0 to 0.3/100 couple-years of follow-up). The transmission rate for anal intercourse was also 0 with a 95% upper-limit of approximately 0.71/100 couple-years of follow up.

 

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: antiretroviralhuman immunodeficiency virus (HIV)
Previous Post

Common surgical procedures linked with increased risk of chronic opioid use

Next Post

The REMATCH trial: Left ventricular assist devices reduce mortality in heart failure [Classics Series]

RelatedReports

HIV care collage: a smiling middle-aged man with an awareness ribbon pinned to his shirt beside a sprig of olive leaves
Chronic Disease

Weekly islatravir plus lenacapavir maintains HIV virologic suppression

December 22, 2025
Institute of Medicine identifies cost variation between geographic regions
Infectious Disease

Ending Ryan White services may increase human immunodeficiency virus incidence

September 8, 2025
HIV care collage: an engraved immune cell inside a ring of torn blue paper, with a small teal shield and a teal ribbon
Infectious Disease

Anal cancer screening cost-effective for men who have sex with men with human immunodeficiency virus aged above 35 years

June 16, 2025
Combined immunotherapy may improve survival in metastatic pancreatic cancer
Infectious Disease

Safety of investigational vaccines against human immunodeficiency virus

April 29, 2025
Next Post
Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The REMATCH trial: Left ventricular assist devices reduce mortality in heart failure [Classics Series]

President Obama reflects on the Affordable Care Act

President Obama reflects on the Affordable Care Act

Catheter ablation more effective than antiarrythmic escalation for ventricular tachycardia: The VANISH trial

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
  • CDC reports increasing early-season influenza activity and at least 900 deaths nationwide
  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.